SteadySharesSteadyShares
The market
MarketsDiscover
Follow the money
Smart MoneyPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in to save your work
Closed
SteadySharesMarketsDiscoverSmart MoneyMy WealthPoliticiansCryptoNews
/
DiscoverHLN.L
HealthcareLSEGBP

Haleon plc

£00123456789.0012345678900123456789+11.0%
52w low (est.) £3.06£4.56 52w high (est.)
Peers
Market data
Market cap
£31.87B
Beta (vs market)
0.24
Sector
Healthcare
Valuation
P/E ratio
20.1x
DCF fair value
£6.93
Margin of safety
+87.2%
Forward P/E
16.0x
PEG ratio
2.56
Dividend yield
1.96%
Quality & efficiency
Moat score
62/100
Return on equity
10.3%
Profit margin
15.1%
Debt / equity
0.52
Growth & analysts
Revenue growth (YoY)
+0.6%
Analyst target
£4.14
Target upside
+11.9%
Analysts covering
17

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Valuation

ValueGrowthProfitHealthIncome54QUALITY
Overall Rating
73
Strong Buy
Strong Buy
Moat Score62
DCF Intrinsic Value
£6.93+87.2% upside

Moat, DCF and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
£31.87B
P/E Ratio
20.1
Dividend Yield
1.96%
Revenue Growth
+0.6%
Profit Margin
15.1%
ROE
10.3%
Debt / Equity
0.52
Beta
0.24
vs Healthcare sector:P/E 20 vs 28 · cheaperMoat 62 vs 7Yield 1.96% vs 0.3%

Statistics

Similar Stocks · Healthcare

LLY73
$920.00+0.7%
AZN.L72
£105.20+0.6%
UNH71
$492.10+1.6%
JNJ70
$146.20-0.2%

Latest News · HLN.L